[The use of cavinton in patients with lacunar stroke developed against the background of diabetes mellitus and arterial hypertension].
Spirin
N N
NN
Pizova
N V
NV
Shadrichev
V A
VA
Filatov
V F
VF
Bakucheva
M V
MV
D000284:Administration, Oral; D000959:Antihypertensive Agents / Q000008:administration & dosage*; D001783:Blood Flow Velocity; D001794:Blood Pressure / Q000187:drug effects; D020520:Brain Infarction / Q000175:diagnosis / Q000188:drug therapy* / Q000209:etiology; D002560:Cerebrovascular Circulation / Q000187:drug effects / Q000502:physiology; D003924:Diabetes Mellitus, Type 2 / Q000150:complications* / Q000503:physiopathology; D004334:Drug Administration Schedule; D005260:Female; D006801:Humans; D006973:Hypertension / Q000150:complications* / Q000503:physiopathology; D007262:Infusions, Intravenous; D008297:Male; D008875:Middle Aged; D016896:Treatment Outcome; D017585:Ultrasonography, Doppler, Transcranial; D014748:Vinca Alkaloids / Q000008:administration & dosage*
D000959:Antihypertensive Agents; D014748:Vinca Alkaloids; C013983:vinpocetine